Correction of endothelial dysfunction after selective homocysteine lowering gene therapy reduces arterial thrombogenicity but has no effect on atherogenesis

Journal of Molecular Medicine

Volumn 89, Issue 10, 2011, Pages 1051-1058

  Jacobs, Frank ^a   Van Craeyveld, Eline ^a   Muthuramu, Ilayaraja ^a   Gordts, Stephanie C ^a   Emmerechts, Jan ^a   Hoylaerts, Marc ^a   Herijgers, Paul ^b   De Geest, Bart ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Atherosclerosis; Endothelial dysfunction; Gene transfer; Homocysteine; Lipoproteins; Thrombosis

Indexed keywords

ADENOVIRUS VECTOR; CHOLESTEROL; CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTICLE; ATHEROGENESIS; BRACHIOCEPHALIC TRUNK; CAROTID ARTERY THROMBOSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; GENE THERAPY; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; MALE; MOUSE; NONHUMAN; THROMBOGENESIS;

ACETYLCHOLINE; ADENOVIRIDAE; ANIMALS; AORTA, THORACIC; ATHEROSCLEROSIS; CAROTID ARTERIES; CHOLESTEROL, HDL; CYSTATHIONINE BETA-SYNTHASE; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; HOMOCYSTEINE; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, LDL; THROMBOSIS; TIME FACTORS; VASODILATION;

EID: 80755142809     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-011-0778-7     Document Type: Article

References (35)

1. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI et al (2000) Endothelial dysfunction in a murine model of mild hyperhomocyst (e) inemia. J Clin Invest 106:483-491 (Pubitemid 30666381)
2. Dayal S, Lentz SR (2008) Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol 28:1596-1605
3. Undas A, Brozek J, Szczeklik A (2005) Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost 94:907-915 (Pubitemid 41645928)
4. Dayal S, Bottiglieri T, Arning E, Maeda N, Malinow MR, Sigmund CD, Heistad DD, Faraci FM, Lentz SR (2001) Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res 88:1203-1209 (Pubitemid 34132522)
5. Hajjar KA (1993) Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest 91:2873-2879 (Pubitemid 23182548)
6. Jacovina AT, Deora AB, Ling Q, Broekman MJ, Almeida D, Greenberg CB, Marcus AJ, Smith JD, Hajjar KA (2009) Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J Clin Invest 119:3384-3394
7. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. Jama 288:2015-2022
8. Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a metaanalysis. BMJ (Clinical research ed) 325:1202
9. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G (2009) Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev: CD006612
10. Potter K, Hankey GJ, Green DJ, Eikelboom JW, Arnolda LF (2008) Homocysteine or renal impairment: which is the real cardiovascular risk factor? Arterioscler Thromb Vasc Biol 28:1158-1164
11. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578-1588
12. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230-236 (Pubitemid 27310438)
13. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R (1985) The natural history of homocystinuria due to cystathionine betasynthase deficiency. Am J Hum Genet 37:1-31 (Pubitemid 15138674)
14. Schimke RN, McKusick VA, Huang T, Pollack AD (1965) Homocystinuria. Studies of 20 families with 38 affected members. Jama 193:711-719
15. McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111-128
16. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
17. Van Linthout S, Lusky M, Collen D, De Geest B (2002) Persistent hepatic expression of human apo A-I after transfer with a helpervirus independent adenoviral vector. Gene Ther 9:1520-1528 (Pubitemid 35414787)
18. Van Craeyveld E, Gordts SC, Nefyodova E, Jacobs F, De Geest B (2011) Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies. J Mol Med 89:555-567
19. Shipchandler MT, Moore EG (1995) Rapid, fully automated measurement of plasma homocyst (e) ine with the Abbott IMx analyzer. Clin Chem 41:991-994
20. Peters LL, Cheever EM, Ellis HR, Magnani PA, Svenson KL, Von Smith R, Bogue MA (2002) Large-scale, high-throughput screening for coagulation and hematologic phenotypes in mice. Physiol Genomics 11:185-193
21. Feng Y, Lievens J, Jacobs F, Hoekstra M, Van Craeyveld E, Gordts SC, Snoeys J, De Geest B (2010) Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis. Cardiovasc Res 88:376-385
22. Wilson KM, McCaw RB, Leo L, Arning E, Lhotak S, Bottiglieri T, Austin RC, Lentz SR (2007) Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 27:233-240 (Pubitemid 46360404)
23. Wang H, Jiang X, Yang F, Gaubatz JW, Ma L, Magera MJ, Yang X, Berger PB, Durante W, Pownall HJ et al (2003) Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood 101:3901-3907 (Pubitemid 36857865)
24. Zhang D, Jiang X, Fang P, Yan Y, Song J, Gupta S, Schafer AI, Durante W, Kruger WD, Yang X et al (2009) Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthasedeficient mice. Circulation 120:1893-1902
25. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376 (Pubitemid 11169009)
26. Fransen P, Van Assche T, Guns PJ, Van Hove CE, De Keulenaer GW, Herman AG, Bult H (2008) Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions. Pflugers Arch 455:811-818 (Pubitemid 350265620)
27. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI et al (2000) Endothelial dysfunction in a murine model of mild hyperhomocyst (e) inemia. J Clin Investig 106:483-491 (Pubitemid 30666381)
28. Dayal S, Wilson KM, Leo L, Arning E, Bottiglieri T, Lentz SR (2006) Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia. Blood 108:2237-2243 (Pubitemid 44497505)
29. Williams KJ, Tabas I (1995) The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15:551-561
30. Tabas I, Williams KJ, Boren J (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116:1832-1844 (Pubitemid 350287108)
31. Steinbrecher UP, Lougheed M (1992) Scavenger receptorindependent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler Thromb 12:608-625
32. Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, Chang RJ, Lin JH, Vilander L, Andrews WH (1992) Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Investig 90:2565-2573 (Pubitemid 23010079)
33. Loscalzo J (2009) Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology. J Clin Invest 119:3203-3205
34. Sauls DL, Lockhart E, Warren ME, Lenkowski A, Wilhelm SE, Hoffman M (2006) Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry 45:2480-2487
35. Colucci M, Cattaneo M, Martinelli I, Semeraro F, Binetti BM, Semeraro N (2008) Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential. J Thromb Haemost 6:1571-1577